Cohance Lifesciences Ltd

  • BSE Code : 543064
  • NSE Symbol : COHANCE
  • ISIN : INE03QK01018
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

up-arrow 311.95 10.50(3.48%)

Open Price ()

308.95

Prev. Close ()

301.45

Volume (No’s)

497,644

Market Cap ()

11,934.18

Low Price ()

304.00

High Price ()

317.50

 

Board Meetings

Start Date End Date Purpose
29-Dec-2025 12-Feb-2026 Cohance Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine-months ending December 31 2025. To consider and approve the financial results for the period ended December 31, 2025. Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025. (As Per NSE Announcement Dated On : 12.02.2026)
19-Jan-2026 19-Jan-2026 Appointment of Mr. Sunil Kumar Singh , Chief Quality Officer, as Senior Management Personnel of the Company
29-Sep-2025 12-Nov-2025 Quarterly Results Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025. (As Per NSE Announcement Dated On : 12.11.2025)
28-Oct-2025 28-Oct-2025 Change in Directors
27-Jun-2025 13-Aug-2025 Cohance Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ending June 30 2025 Outcome of the Board Meeting (As Per BSE Announcement Dated on: 13.08.2025)

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew